The National Institute of Antimicrobial Resistance Research and Education (NIAMRRE), today announced Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), as a new industry member. Merck Animal Health develops, manufactures, and markets a range of veterinary medicines and services.
“By joining NIAMRRE, Merck Animal Health is taking its long-standing commitment to the global fight against infectious disease to the next level,” said Dr. Paul Plummer, executive director of NIAMRRE. “Their support for the responsible use of antibiotics to improve and maintain the health of companion and food-producing animals will create a global impact as we work toward the goal of One Health: achieving the best health for people, animals, plants, and the environment.”
The health and economic consequences of antimicrobial resistance (AMR) are considerable and costly, making it a serious threat to human and animal health, which requires an organized response. Membership with NIAMRRE reflects Merck Animal Health’s belief that collaborating with a broad group of stakeholders will further advance optimal animal health outcomes.
“This is an exciting relationship with a global company that is committed to a holistic approach to disease prevention and management through evidence-based innovations and treatments that have a positive impact on the wellbeing of animals,” said Dr. Plummer. “We are eager for Merck Animal Health to share their dedication to addressing AMR and promoting antimicrobial stewardship through cross-sector collaboration with our other members.”
Merck Animal Health joins NIAMRRE's diverse membership roster, with members representing academic institutions, commodity groups, pharma and health organizations, retailers, nonprofits and member associations, and startup companies. Organizations committed to cross-sector engagement to stop the spread of AMR may apply for membership. Members are accepted year-round for organizations dedicated to advancing the One Health approach—a collaborative methodology to achieve optimal health outcomes between people, animals, plants, and their shared environment.
To find out more about Merck Animal Health, visit www.merck.com.
###
ABOUT NIAMRRE
The National Institute of Antimicrobial Resistance Research and Education provides local, national, and international leadership in combating antimicrobial resistance (AMR). Based at the Iowa State University Research Park, in Ames, Iowa, NIAMRRE drives collaborative and integrative research, education, and engagement to solve AMR challenges and benefit society using a One Health approach. For more information, visit www.niamrre.org and follow us on Facebook, LinkedIn, and Twitter.
ABOUT MERCK ANIMAL HEALTH
For more than a century, Merck, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of Merck. Through its commitment to The Science of Healthier Animals®, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com or connect with us on LinkedIn, Facebook, and Twitter at @MerckAH.